Literature DB >> 34088747

Anti-body antibodies in COVID-19.

Andrew H Lichtman1.   

Abstract

A new high-throughput screening technique detected autoantibodies in COVID-19 patients specific for many different immunomodulatory extracellular and cell surface proteins, several of which were associated with disease severity and clinical outcomes.
Copyright © 2021, American Association for the Advancement of Science.

Entities:  

Year:  2021        PMID： 34088747     DOI： 10.1126/sciimmunol.abj7173

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  1 in total

1.  Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity.

Authors:  Otavio Cabral-Marques; Gilad Halpert; Lena F Schimke; Gabriela Riemekasten; Yehuda Shoenfeld; Yuri Ostrinski; Aristo Vojdani; Gabriela Crispim Baiocchi; Paula Paccielli Freire; Igor Salerno Filgueiras; Israel Zyskind; Miriam T Lattin; Florian Tran; Stefan Schreiber; Alexandre H C Marques; Desirée Rodrigues Plaça; Dennyson Leandro M Fonseca; Jens Y Humrich; Antje Müller; Lasse M Giil; Hanna Graßhoff; Anja Schumann; Alexander Hackel; Juliane Junker; Carlotta Meyer; Hans D Ochs; Yael Bublil Lavi; Carmen Scheibenbogen; Ralf Dechend; Igor Jurisica; Kai Schulze-Forster; Jonathan I Silverberg; Howard Amital; Jason Zimmerman; Harry Heidecke; Avi Z Rosenberg
Journal:  Nat Commun       Date:  2022-03-09       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.